TRPV1 and Alzheimer disease: Although PAC-14028 shows a promising anti-itch effect in AD, a randomized clinical trial failed to find a symptomatic benefit of another TRPV1 antagonist, SB-705498, for histaminergic or non-histaminergic induced itch [155].